Medical Scientist Training Program, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Clin Infect Dis. 2023 Feb 8;76(3):487-496. doi: 10.1093/cid/ciac714.
Staphylococcus aureus represents the leading cause of complicated bloodstream infections among persons who inject drugs (PWID). Standard of care (SOC) intravenous (IV) antibiotics result in high rates of treatment success but are not feasible for some PWID. Transition to oral antibiotics may represent an alternative treatment option.
We evaluated all adult patients with a history of injection drug use hospitalized from January 2016 through December 2021 with complicated S. aureus bloodstream infections, including infective endocarditis, epidural abscess, vertebral osteomyelitis, and septic arthritis. Patients were compared by antibiotic treatment (standard of care intravenous [SOC IV] antibiotics, incomplete IV therapy, or transition from initial IV to partial oral) using the primary composite endpoint of death or readmission from microbiologic failure within 90 days of discharge.
Patients who received oral antibiotics after an incomplete IV antibiotic course were significantly less likely to experience microbiologic failure or death than patients discharged without oral antibiotics (P < .001). There was no significant difference in microbiologic failure rates when comparing patients who were discharged on partial oral antibiotics after receiving at least 10 days of IV antibiotics with SOC regimens (P > .9).
Discharge of PWID with partially treated complicated S. aureus bacteremias without oral antibiotics results in high rates of morbidity and should be avoided. For PWID hospitalized with complicated S. aureus bacteremias who have received at least 10 days of effective IV antibiotic therapy after clearance of bacteremia, transition to oral antibiotics with outpatient support represents a potential alternative if the patient does not desire SOC IV antibiotic therapy.
金黄色葡萄球菌是导致注射吸毒者(PWID)发生复杂性血流感染的主要原因。标准的静脉内(IV)抗生素治疗方法成功率高,但对于某些 PWID 来说并不可行。转为口服抗生素可能是一种替代治疗选择。
我们评估了 2016 年 1 月至 2021 年 12 月期间所有有注射吸毒史、患有金黄色葡萄球菌复杂性血流感染(包括感染性心内膜炎、硬膜外脓肿、脊椎骨髓炎和化脓性关节炎)的成年住院患者。根据抗生素治疗方法(标准的静脉内 [SOC IV] 抗生素、不完全 IV 治疗或从初始 IV 转为部分口服)将患者进行比较,主要复合终点为出院后 90 天内因微生物学失败而死亡或再入院。
接受不完全 IV 抗生素疗程后接受口服抗生素治疗的患者,与未接受口服抗生素治疗的患者相比,微生物学失败或死亡的发生率明显较低(P <.001)。与接受 SOC 方案治疗的患者相比,至少接受 10 天 IV 抗生素治疗后出院时接受部分口服抗生素治疗的患者的微生物学失败率没有显著差异(P >.9)。
对于未接受口服抗生素治疗且部分治疗的复杂性金黄色葡萄球菌菌血症的 PWID,出院后发病率较高,应避免这种情况。对于已清除菌血症、至少接受 10 天有效 IV 抗生素治疗后住院的复杂性金黄色葡萄球菌菌血症 PWID,如果患者不希望接受 SOC IV 抗生素治疗,过渡到口服抗生素并提供门诊支持是一种潜在的替代方法。